Search clinical trials for: liposomal Amphotericine B

Total 8690 results

Assistance Publique - Hôpitaux de Paris

Terminated

Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia

Malignant Hemopathy | Duration of Neutropenia Following Chemotherapy > 10 Days

France
University of Pittsburgh
Astellas Pharma US, Inc.

Completed

Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study

Lung Transplantation | Fungal Infections

United States
University of Pittsburgh
Enzon Pharmaceuticals, Inc.

Terminated

Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant Recipients

Lung Diseases | Lung Transplantation

United States
Alkermes, Inc.

Completed

The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis

HIV Infections | Meningitis, Cryptococcal

United States
TTY Biopharm

Unknown

Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis

Cryptococcal Meningitis

Taiwan
Cornea Research Foundation of America

Withdrawn

Evaluation of Amphotericin B in Optisol-GS for Prevention of Post-Keratoplasty Fungal Infections.

Fuchs' Endothelial Dystrophy

United States
Hui Bu

Unknown

Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis

Cryptococcal Meningitis
Bristol-Myers Squibb

Completed

Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients

HIV Infections | Candidiasis, Esophageal

United States
Banaras Hindu University

Completed

Amphotericin B Treatment in Visceral Leishmaniasis

Visceral Leishmaniasis

India
Bayside Health
Gilead Sciences

Unknown

Intermittent Liposomal Amphotericin B Primary Prophylaxis

Acute Myeloid Leukemia

Australia
Matinas BioPharma Nanotechnologies, Inc.
University of Minnesota

Not yet recruiting

Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3 (EnACT3)

Cryptococcal Meningitis
Federal University of Health Science of Porto Alegre

Not yet recruiting

Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS (L-AmB_phase3)

Fungal Infection | Immunosuppression | AIDS and Infections | Disseminated Histoplasma Capsulatum Infection

Brazil
Banaras Hindu University

Completed

A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar

Visceral Leishmaniasis

India
Gilead Sciences

Completed

Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia (AmBiGuard)

Invasive Fungal Disease

United Kingdom
University of Brasilia
Ministry of Health, Brazil

Completed

Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children (LVTO)

Visceral Leishmaniasis

Brazil
Merck Sharp & Dohme LLC

Completed

MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)

Aspergillosis
Merck Sharp & Dohme LLC

Terminated

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)

Candidiasis, Invasive
H. Jaap Bonjer, PhD
Dutch Digestive Diseases Foundation

Terminated

Does Administration of Antibiotics in Patients Undergoing Surgery for Colorectal Cancer Result in Less Complications and Better Prognosis? (SELECT)

Colorectal Cancer

Netherlands
University of Brasilia
Ministry of Health, Brazil; Conselho Nacional de Desenvolvimento Científico... and other collaborators

Terminated

Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil (LVBrasil)

Visceral Leishmaniasis

Brazil
PATH
World Health Organization

Completed

Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis

Visceral Leishmaniasis

India
Fundacion SEIMC-GESIDA
Pfizer

Completed

Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients (AVALTRA)

Fungal Infection | Liver Disease

Spain
Gilead Sciences

Completed

PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia

Leukemia

France
Aronex Pharmaceuticals

Completed

Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Infection | Multiple Myeloma and Plasma Cell Neoplasm

United States
Gilead Sciences

Completed

PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation

Fungus Diseases

Italy
Gilead Sciences

Completed

Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment

Invasive Aspergillosis | Other Fungal Infections
MEDSI Clinical Hospital 1, ICU

Recruiting

Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria

Respiratory Tract Infections | Pneumonia | Sepsis | Critical Illness | Respiratory Distress Syndrome | Pneumonia, Ventilator-Associated | Bloodstream Infection

Russian Federation
Medecins Sans Frontieres, Netherlands

Completed

Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh

Post-kala-azar Dermal Leishmaniasis
Shanghai Public Health Clinical Center

Unknown

AmB Dose for Cryptococcal Meningitis

HIV Infections | Cryptococcal Meningitis

China
Gilead Sciences

Completed

CRITIC - Treatment of Candidemia and Invasive Candidiasis (CRITIC)

Candidemia | Invasive Candidiasis

Italy
Singapore General Hospital
National University Hospital, Singapore

Completed

To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early

Aspergillosis

Singapore
Drugs for Neglected Diseases

Completed

Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis

Visceral Leishmaniasis

India
First Affiliated Hospital of Zhejiang University
Wenzhou Central Hospital

Unknown

Three Induction Treatments on Cryptococcal Meningitis (TITOC)

HIV/AIDS | Cryptococcal Meningitis

China
University of Brasilia

Recruiting

Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly

Leishmaniasis, Mucocutaneous | Leishmaniasis; Brazilian

Brazil
Mahidol University

Completed

Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis (amphotericin)

Fungal Infection | Onychomycosis | Fungus, Nail

Thailand
Dongkook Pharmaceutical Co., Ltd.

Completed

Pharmacokinetics and Safety of AmBisome and DKF-5122

Invasive Fungal Infections | Neutropenic Fever

Korea, Republic of
The University of Texas Health Science Center,...

Terminated

Ambisome in Liver Transplant Patients

Liver Transplantation

United States
Novartis Pharmaceuticals

Terminated

Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS

Cryptococcal Meningitis

South Africa
Huashan Hospital

Enrolling by invitation

Amphotericin B for Non-HIV Cryptococcal Meningitis Patients (ABNCM)

Antifungal Agents | Cryptococcal Meningitis

China
Radboud University Medical Center

Completed

Liposomal Amphotericin B (AmBisome) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ASPEN)

Morbid Obesity

Netherlands
Nanfang Hospital, Southern Medical University

Not yet recruiting

A Clinical Study on the Efficacy and Safety of ABCD in the Treatment of Patients With Invasive Fungal Disease

Invasive Fungal Disease
CSPC Ouyi Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus

Invasive Aspergillosis | Invasive Candidiasis

China
University Health Network, Toronto

Suspended

Safety and Efficacy Study of Inhaled AmBisome for Prevention of Aspergillus Colonization in Lung Transplant Recipients

Lung Transplant Recipient

Canada
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown

Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis

Invasive Aspergillosis | Invasive Candidiasis
Lundquist Institute for Biomedical Innovation at...
Novartis; Gilead Sciences; Astellas Pharma Inc

Completed

The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study

Mucormycosis

United States
Drugs for Neglected Diseases
Novartis Pharmaceuticals

Recruiting

A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis

Primary Visceral Leishmaniasis

India
National Institute of Allergy and Infectious Diseases...

Withdrawn

SCH708980 With and Without AmBisome for Visceral Leishmaniasis

Effects of Immunotherapy | Leishmaniasis

India
European Organisation for Research and Treatment...

Completed

Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis

Infection | Pulmonary Complications

France, Spain, Switzerland, Australia, Sweden, Luxembourg, Belgium, Germany, United Kingdom, Hungary, Italy, Israel, Ireland, Netherlands, United States
Alessandro Pasqualotto
Hospital de Clinicas de Porto Alegre; Irmandade Santa Casa de Misericórdia... and other collaborators

Completed

Randomized Trial of Liposomal Amphotericin B for Histoplasmosis in AIDS Patients

AIDS | Histoplasmosis

Brazil
Postgraduate Institute of Medical Education and...

Recruiting

Amphotericin Versus Posaconazole for Pulmonary Mucormycosis

Mucormycosis; Pulmonary (Etiology)

India
Vical

Terminated

VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults

Invasive Aspergillosis | Invasive Pulmonary Aspergillosis

United States, Korea, Republic of, Canada, Belgium, France, Germany

Search clinical trials for: liposomal Amphotericine B

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations